Inogen EVP sells 10,938 shares at $6.5959

Rhea-AI Filing Summary

Inogen Inc executive Jennifer M. Yi Boyer, EVP Enterprise Enablement and Chief HR Officer, sold 10,938 shares of common stock in an open-market transaction on July 1, 2026 at a weighted average price of $6.5959 per share under a pre-arranged Rule 10b5-1 trading plan.

After this sale, she directly holds 5,039 shares of Inogen common stock.

Insider Trade Summary 10b5-1

Net Seller: 10,938 shares

Net Sell 1 txn

Insider Yi Boyer Jennifer M

Role EVP Entrprs Enblmnt, Ch HR Off

Sold 10,938 shs ($72K)

Type	Security	Shares	Price	Value
Sale	Common Stock	10,938	$6.5959	$72K

Holdings After Transaction: Common Stock — 5,039 shares (Direct)

Footnotes (2)

1. F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2026.
2. F2. Represents the weighted average share price of an aggregate total of 10,938 shares sold in the price range of $6.48 to $6.70 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Key Figures

Shares sold: 10,938 shares Weighted average sale price: $6.5959 per share Shares held after transaction: 5,039 shares +1 more

4 metrics

Shares sold 10,938 shares Open-market sale on July 1, 2026

Weighted average sale price $6.5959 per share Aggregate 10,938 shares sold in $6.48–$6.70 range

Shares held after transaction 5,039 shares Direct ownership following reported sale

Trading plan adoption date February 27, 2026 Rule 10b5-1 plan governing July 1, 2026 sale

Key Terms

Rule 10b5-1 trading plan, open-market sale, weighted average share price

3 terms

Rule 10b5-1 trading plan regulatory

"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

weighted average share price financial

"Represents the weighted average share price of an aggregate total of 10,938 shares sold"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Inogen Inc (INGN) report for Jennifer M. Yi Boyer?

Inogen executive Jennifer M. Yi Boyer reported selling 10,938 shares of common stock. The shares were sold in an open-market transaction at a weighted average price of $6.5959 per share on July 1, 2026 under a Rule 10b5-1 trading plan.

At what price were the Inogen Inc (INGN) shares sold in this Form 4?

The reported Inogen shares were sold at a weighted average price of $6.5959 per share. Footnotes state the 10,938 shares were sold in a price range between $6.48 and $6.70, with full breakdowns available upon request to the company or regulators.

How many Inogen Inc (INGN) shares does Jennifer M. Yi Boyer hold after the sale?

After the reported sale, Jennifer M. Yi Boyer directly holds 5,039 Inogen common shares. This post-transaction holding reflects her remaining direct ownership position as disclosed in the Form 4 following the 10,938-share open-market sale.

Was the Inogen Inc (INGN) insider sale made under a Rule 10b5-1 plan?

Yes. The Form 4 states the sales were effected under a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2026. Such plans pre-schedule trades, reducing the significance of trade timing for interpreting insider sentiment.

Who is the insider involved in the Inogen Inc (INGN) Form 4 filing?

The insider is Jennifer M. Yi Boyer, an officer of Inogen Inc. She serves as Executive Vice President of Enterprise Enablement and Chief Human Resources Officer, and the Form 4 reports her open-market sale of 10,938 shares of common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/06/2026 - 04:36 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Yi Boyer Jennifer M

(Last) (First) (Middle)

C/O INOGEN, INC.

500 CUMMINGS CENTER, SUITE 2800

(Street)

BEVERLY MASSACHUSETTS 01915

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Inogen Inc [ INGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP Entrprs Enblmnt, Ch HR Off

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		S(1)		10,938	D	$6.5959(2)	5,039	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2026.

2. Represents the weighted average share price of an aggregate total of 10,938 shares sold in the price range of $6.48 to $6.70 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

	/s/ Mary Wright, as Attorney-in-Fact	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)